This study compares in vivo efficacy and specificity of the three NK c
ell depleting antibodies anti-asialo GM(1), anti-NK 1.1 and the recent
ly described TM beta 1, which is directed against the interleukin-2 re
ceptor beta chain. All three antibodies are equally efficacious as ass
essed by abolishing NK mediated cytolytic activity induced by a high d
ose virus infection or Poly IC against YAC-1 targets. Similarly, the g
eneration of virus-specific cytotoxic T cells (CTL) was unimpaired aft
er NK a depletion in two different virus infections. However, if mice
are treated with the antibodies several days after virus infection, wh
en strong CTL responses have already been generated, anti-asialo GM(1)
and-to a lesser extent-also TM beta 1 have a significant effect on CT
L activity. Only after treatment with anti-NK 1.1 antibody, CTL activi
ty was not significantly impaired. We conclude, that of the NK depleti
ng antibodies currently available, anti-NK 1.1 allows the best differe
ntiation of activated CTL and NK cells in vivo.